Challenges with biomarkers in cancer drug discovery and development-Reference-Cited by-同舟云学术

Challenges with biomarkers in cancer drug discovery and development

Published:2018-05-24 Issue:8 Volume:13 Page:685-690
ISSN:1746-0441
Container-title:Expert Opinion on Drug Discovery
language:en
Short-container-title:Expert Opinion on Drug Discovery

Author:

Ileana Dumbrava Ecaterina¹,Meric-Bernstam Funda¹²³,Yap Timothy A.¹²⁴⁵

Affiliation:

1. Department of Investigational Cancer Therapeutics (Phase I Program), The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

2. Khalifa Institute for Personalized Cancer Therapy, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

3. Department of Breast Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

4. Institute for Applied Cancer Science, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA

5. Department of Thoracic/Head and Neck Medical Oncology

Funder

The Sheikh Khalifa Al Nahyan Ben Zayed Institute for Personalized Cancer Therapy, Cancer Prevention Research Institute of Texas (CPRIT) Precision Oncology Decision Support Core

the MD Anderson Cancer Center Support grant

Publisher

Informa UK Limited

Subject

Drug Discovery

Link

https://www.tandfonline.com/doi/pdf/10.1080/17460441.2018.1479740

Reference28 articles.

1. High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial

2. Overcoming implementation challenges of personalized cancer therapy

3. A Decision Support Framework for Genomically Informed Investigational Cancer Therapy

4. The right drugs at the right time for the right patient: the MD Anderson precision oncology decision support platform

5. Biomarkers and surrogate endpoints: Preferred definitions and conceptual framework

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Antibody drug conjugates for glioblastoma: current progress towards clinical use;Expert Opinion on Biological Therapy;2023-11-02

2. N-of-1 Trials in Cancer Drug Development;Cancer Discovery;2023-04-18

3. Artificial intelligence aids in development of nanomedicines for cancer management;Seminars in Cancer Biology;2023-02

4. Recent advances in transcriptomic biomarker detection for cancer;Transcriptome Profiling;2023

5. Flexible Sensing Systems for Cancer Diagnostics;Microfluidics and Biosensors in Cancer Research;2022